NCT06336135View on ClinicalTrials.gov

Reduction in Symptoms After Laser Therapy With Acorn aHFS

Active, not recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

March 25, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

December 31, 2026

Conditions
Skin Aging
Interventions
OTHER

autologous hair follicle derived secretome

aHFS is a cosmetic topical intended to be applied to the human body after skin resurfacing cosmetic procedures. aHFS is produced from the plucked hair follicles of each individual, making it autologous.

Trial Locations (1)

L3R0M3

Rejuuv Medi Spa, Markham

All Listed Sponsors
lead

Acorn Biolabs Inc.

INDUSTRY

NCT06336135 - Reduction in Symptoms After Laser Therapy With Acorn aHFS | Biotech Hunter | Biotech Hunter